YBX1, a newly discovered m5C binding protein that regulates the stability of mRNA in cytoplasm, and is overexpressed in most cancers, is associated with tumor cell proliferation, anti-apoptosis, migration and prognosis, and is expected to be an ideal diagnostic biomarker and a candidate therapeutic target [38]. Here, YBX1 is linked to cancer.